Archive for: Break Out Room Presentations

square

Strategic Infrastructure Issues 2

A discussion of international clinical trial infrastructure models and what is necessary to improve Canada’s competitiveness in clinical research. Author/Presenter: Dr. Jean-Marie Leclerc, Chief Scientific Officer and Senior Vice President, Clinical and Regulatory Affairs, Novartis  

square

Strategic Infrastructure Issues 1

A discussion of international clinical trial infrastructure models and what is necessary to improve Canada’s competitiveness in clinical research. Author/Presenter: Dr. Rob McMaster, Vice President Research, Vancouver Coastal Health  

square

Cost Issues

Presentation by L. Bennett, and Dr. S. Choudhri at the 2011 National Clinical Trials Summit on Cost Structure. Author/Presenter: Linda Bennett, Executive Director, Canadian Rheumatology Research Consortium & Dr. Shurjeel Choudhri, Senior Vice-President and Head, Medical and Scientific Affairs, Bayer Inc.

square

Admininstrative Issues

Presentation by Dr. N. Maresky & K. Arts at the 2011 National Clinical Trials Summit on Improving Administrative Aspects of the Canadian Clinical Trials Environment. Author/Presenter: Dr. Neil Maresky, Vice-President, Scientific Affairs, AstraZeneca Inc. & Karen Arts, Director, Business Development, Clinical Trials, Ontario Institute for Cancer Research & Co-Founder and Chair of Board of Directors […]

square

Recruitment & Retention

Presentation by D. Simmons & S. Gazel at the 2011 National Clinical Trials Summit on Patient Recruitment Retention and Follow-up Author/Presenter: Diane Simmons, President and CEO, Center for Information and Study on Clinical Research Participation & Sandra Gazel, Associate Director, Clinical Operations, Abbott

square

Streamlining Ethics Review

Presentation by L. Barrett-Smith & Dr. S. Glezer at the 2011 National Clinical Trials Summit on Streamlining Ethics Review in Canada, titled: A matter of Balance Author/Presenter: Linda Barrett-Smith, Drector, Research Ethics & Alberta Clinical Research Consortium (ACRC) & Dr. Stanislav Glezer, Vice-President Medical Affairs, Sanofi-Aventis